Bugianesi Elisabetta, Pagotto Uberto, Manini Rita, Vanni Ester, Gastaldelli Amalia, de Iasio Rosaria, Gentilcore Elena, Natale Stefania, Cassader Maurizio, Rizzetto Mario, Pasquali Renato, Marchesini Giulio
Division of Gastroenterology, University of Turin, Ospedale San Giovanni Battista, Corso Bramante 88, I-10126 Torino, Italy.
J Clin Endocrinol Metab. 2005 Jun;90(6):3498-504. doi: 10.1210/jc.2004-2240. Epub 2005 Mar 29.
Plasma levels of adiponectin are decreased in patients with nonalcoholic fatty liver disease (NAFLD), but the relationship among plasma adiponectin, insulin sensitivity, and histological features is unclear. In 174 NAFLD patients and 42 controls, we examined plasma adiponectin concentrations in relation to 1) lipid profile, indices of insulin resistance, and features of the metabolic syndrome (n = 174); 2) hepatic insulin resistance (clamp technique with tracer infusion) (10 patients); and 3) histological features at liver biopsy (n = 116). When the data from all subjects were combined, plasma adiponectin levels were positively associated with increased age, female gender, and plasma high-density lipoprotein levels, and negatively associated with waist circumference, body mass index, triglycerides, indices of insulin resistance, and aminotransferase levels, and also predicted the presence of the metabolic syndrome. In step-wise regression, increased age, female gender, waist circumference, triglyceride levels, and homeostasis model assessment independently associated with adiponectin (adjusted R(2), 0.329). In NAFLD, adiponectin was only associated with increased age, female gender, and triglycerides (adjusted R(2), 0.245). When the measured histological parameters were included in the model, plasma adiponectin levels were also inversely proportional to the percentage of hepatic fat content (adjusted R(2), 0.221), whereas necroinflammation and fibrosis did not fit in the model. Adiponectin was negatively correlated with insulin-suppressed endogenous glucose production during the clamp (P = 0.011). The results demonstrate that decreased levels of circulating adiponectin in NAFLD are related to hepatic insulin sensitivity and to the amount of hepatic fat content. Hypoadiponectinemia in NAFLD is part of a metabolic disturbance characterized by ectopic fat accumulation in the central compartment.
非酒精性脂肪性肝病(NAFLD)患者的血浆脂联素水平降低,但血浆脂联素、胰岛素敏感性和组织学特征之间的关系尚不清楚。在174例NAFLD患者和42例对照中,我们研究了血浆脂联素浓度与以下因素的关系:1)血脂谱、胰岛素抵抗指标和代谢综合征特征(n = 174);2)肝脏胰岛素抵抗(示踪剂输注钳夹技术)(10例患者);3)肝活检的组织学特征(n = 116)。当合并所有受试者的数据时,血浆脂联素水平与年龄增加、女性性别和血浆高密度脂蛋白水平呈正相关,与腰围、体重指数、甘油三酯、胰岛素抵抗指标和转氨酶水平呈负相关,并且还可预测代谢综合征的存在。在逐步回归分析中,年龄增加、女性性别、腰围、甘油三酯水平和稳态模型评估与脂联素独立相关(调整R²,0.329)。在NAFLD中,脂联素仅与年龄增加、女性性别和甘油三酯相关(调整R²,0.245)。当将测量的组织学参数纳入模型时,血浆脂联素水平也与肝脂肪含量百分比呈反比(调整R²,0.221),而坏死性炎症和纤维化不适合该模型。脂联素与钳夹期间胰岛素抑制的内源性葡萄糖生成呈负相关(P = 0.011)。结果表明,NAFLD患者循环脂联素水平降低与肝脏胰岛素敏感性和肝脂肪含量有关。NAFLD中的低脂联素血症是一种以中央隔室异位脂肪堆积为特征的代谢紊乱的一部分。